Randomized trial shows dietary silymarin and chitosan nanoparticles improve liver function and antioxidant defense in zebrafish, suggesting their utility as aquaculture feeds.
The present study aimed to evaluate the effects of dietary silymarin (SM), chitosan nanoparticles (CNPs), and silymarin-coated chitosan nanoparticles (SM-CNPs) on growth performance, liver function, antioxidant status, and the expression of antioxidant-related genes in zebrafish ( Danio rerio ). A total of 480 zebrafish (initial weight: 0.25 ± 0.005 g) were randomly assigned to four dietary treatments: a control diet without additives and diets supplemented with SM, CNPs, or SM-CNPs at 100 mg kg⁻ 1 feed for 8 weeks. Growth performance was not significantly affected by any dietary treatment ( P > 0.05). However, fish fed SM- or CNP-supplemented diets exhibited significantly lower serum alkaline phosphatase (ALP) and alanine aminotransferase (ALT) activities than the control group ( P < 0.05), indicating improved liver function. Moreover, dietary SM and SM-CNPs significantly reduced hepatic malondialdehyde (MDA) levels ( P < 0.05), while all supplemented diets significantly enhanced the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) compared with the control ( P < 0.05). Consistently, the expression of sod and gpx genes was significantly upregulated in fish receiving the supplemented diets ( P < 0.05). These findings demonstrate that dietary supplementation with SM, particularly when combined with chitosan nanoparticles, effectively enhances antioxidant defense and liver health without affecting growth performance, supporting its potential application as a functional feed additive for improving fish health in aquaculture.
No takes yet. Share an insight, caveat, or question.
Moradinia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: